Benutzer: Gast  Login
Titel:

Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial.

Dokumenttyp:
Article; Clinical Trial Protocol; Journal Article
Autor(en):
Wagner, Elias; Strube, Wolfgang; Görlitz, Thomas; Aksar, Aslihan; Bauer, Ingrid; Campana, Mattia; Moussiopoulou, Joanna; Hapfelmeier, Alexander; Wagner, Petra; Egert-Schwender, Silvia; Bittner, Robert; Eckstein, Kathrin; Nenadić, Igor; Kircher, Tilo; Langguth, Berthold; Meisenzahl, Eva; Lambert, Martin; Neff, Sigrid; Malchow, Berend; Falkai, Peter; Hirjak, Dusan; Böttcher, Kent-Tjorben; Meyer-Lindenberg, Andreas; Blankenstein, Christiane; Leucht, Stefan; Hasan, Alkomiet
Abstract:
BACKGROUND: Quick symptomatic remission after the onset of psychotic symptoms is critical in schizophrenia treatment, determining the subsequent disease course and recovery. In this context, only every second patient with acute schizophrenia achieves symptomatic remission within three months of initiating antipsychotic treatment. The potential indication extension of clozapine-the most effective antipsychotic-to be introduced at an earlier stage (before treatment-resistance) is supported by seve...     »
Zeitschriftentitel:
Pharmacopsychiatry
Jahr:
2023
Band / Volume:
56
Heft / Issue:
5
Seitenangaben Beitrag:
169-181
Volltext / DOI:
doi:10.1055/a-2110-4259
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/37506738
Print-ISSN:
0176-3679
TUM Einrichtung:
Lehrstuhl für Allgemeinmedizin (Prof. Schneider); Lehrstuhl für Medizinische Informatik (Prof. Boeker)
 BibTeX